Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.000
+0.030 (1.01%)
At close: Aug 8, 2025, 4:00 PM
3.030
+0.030 (1.00%)
After-hours: Aug 8, 2025, 7:58 PM EDT
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $739.35 million as of August 8, 2025. Its market cap has decreased by -45.46% in one year.
Market Cap
739.35M
Enterprise Value
725.97M
1-Year Change
-45.46%
Ranking
Category
Stock Price
$3.00
Market Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $739.35M, a decrease of -44.20%. That is a compound annual growth rate of -12.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 739.35M | 103.16% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
| Feb 4, 2021 | 1.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 573.02B |
| Johnson & Johnson | 410.86B |
| AbbVie | 350.43B |
| Abbott Laboratories | 229.08B |
| AstraZeneca | 228.71B |
| Novartis AG | 221.76B |
| UnitedHealth Group | 219.83B |
| Novo Nordisk | 200.63B |